Evidence for an association between the SRD5A2 (type II steroid 5α-reductase) locus and prostate cancer in Italian patients

Disease Markers

Volumn 16, Issue 3-4, 2000, Pages 147-150

  Margiotti, K ^h   Sangiuolo, F ^a   De Luca, A ^a   Froio, F ^c   Pearce, C L ^d   Ricci Barbini, V ^e   Micali, F ^a   Bonafe, M ^f   Franceschi, C ^f   Dallapiccola, B ^g   Novelli, G ^a   Reichardt, J K V ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Ospedale Villa S Pietro   (Italy)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^f UNIVERSITY OF BOLOGNA   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h NONE

Author keywords

Polymorphic variant; Prostate cancer; Prostate cancer risk; SRD5A2 gene

Indexed keywords

ALANINE; LEUCINE; STEROID 5ALPHA REDUCTASE; THREONINE;

ADULT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT;

EID: 0034436935     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2000/683607     Document Type: Article

References (20)

1. p53 variants predisposing to cancer are present in healthy centenarians
2. Response of rat ventral prostate to a new and novel 5 alpha-reductase inhibitor
3. Progress in prostate cancer
4. Epidemiological and socioeconomic aspects of Italian centenarians
5. Physiological control of prostatic growth: An overview
6. The molecular biology of the prostate
7. Unusual length polymorphism in human steroid 5α-reductase type 2 gene (SRD5A2)
8. Serological precursors of cancer: Serum hormones and risk of subsequent prostate cancer, Cancer Epidemiol
9. Genetic aspects of prostate cancer
10. A prevalent missense substitution that modulates activity of prostatic steroid 5 alpha-reductase
11. Association of missense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA
12. Biochemical and pharmacogenetic dissection of human steroid 5α-reductase type II
13. The development of prostate adenocarcinoma in Nb rats following prolonged sex hormone administration
14. Genetic variability of the human SRD5A2 gene: Implications for prostate cancer risk
15. Serum testosterone levels in healthy young black and white men
16. 5 Alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males
17. Prostate cancer
18. Androgen metabolism and prostate cancer: Establishing a model of genetic susceptibility
19. Hormonal effects of an orally active 4-azasteroid inhibitor of 5 alpha-reductase in humans